000862752 001__ 862752
000862752 005__ 20210130001608.0
000862752 0247_ $$2doi$$a10.1016/j.chemphyslip.2019.02.009
000862752 0247_ $$2ISSN$$a0009-3084
000862752 0247_ $$2ISSN$$a1873-2941
000862752 0247_ $$2Handle$$a2128/22181
000862752 0247_ $$2pmid$$apmid:30826264
000862752 0247_ $$2WOS$$aWOS:000464480000008
000862752 0247_ $$2altmetric$$aaltmetric:57105515
000862752 037__ $$aFZJ-2019-02994
000862752 082__ $$a530
000862752 1001_ $$0P:(DE-HGF)0$$aFalke, Marcel$$b0
000862752 245__ $$aα-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
000862752 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2019
000862752 3367_ $$2DRIVER$$aarticle
000862752 3367_ $$2DataCite$$aOutput Types/Journal article
000862752 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1557840054_24070
000862752 3367_ $$2BibTeX$$aARTICLE
000862752 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000862752 3367_ $$00$$2EndNote$$aJournal Article
000862752 520__ $$aAggregation of the protein α-Synuclein (αSyn) is of great interest due to its involvement in the pathology of Parkinson’s disease. However, under in vitro conditions αSyn is very soluble and kinetically stable for extended time periods. As a result, most αSyn aggregation assays rely on conditions that artificially induce or enhance aggregation, often by introducing rather non-native conditions. It has been shown that αSyn interacts with membranes and conditions have been identified in which membranes can promote as well as inhibit αSyn aggregation. It has also been shown that αSyn has the intrinsic capability to assemble lipid-protein-particles, in a similar way as apolipoproteins can form lipid-bilayer nanodiscs. Here we show that these αSyn-lipid particles (αSyn-LiPs) can also effectively induce, accelerate or inhibit αSyn aggregation, depending on the applied conditions. αSyn-LiPs therefore provide a general platform and additional tool, complementary to other setups, to study various aspects of αSyn amyloid fibril formation.
000862752 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000862752 588__ $$aDataset connected to CrossRef
000862752 7001_ $$00000-0002-2720-0657$$aVictor, Julian$$b1
000862752 7001_ $$0P:(DE-HGF)0$$aWördehoff, Michael M.$$b2
000862752 7001_ $$0P:(DE-HGF)0$$aPeduzzo, Alessia$$b3
000862752 7001_ $$0P:(DE-Juel1)177882$$aZhang, Tao$$b4
000862752 7001_ $$0P:(DE-Juel1)132018$$aSchröder, Gunnar F.$$b5
000862752 7001_ $$00000-0003-1161-3622$$aBuell, Alexander K.$$b6
000862752 7001_ $$0P:(DE-Juel1)166306$$aHoyer, Wolfgang$$b7
000862752 7001_ $$0P:(DE-Juel1)156341$$aEtzkorn, Manuel$$b8$$eCorresponding author
000862752 773__ $$0PERI:(DE-600)1496839-3$$a10.1016/j.chemphyslip.2019.02.009$$gVol. 220, p. 57 - 65$$p57 - 65$$tChemistry and physics of lipids$$v220$$x0009-3084$$y2019
000862752 8564_ $$uhttps://juser.fz-juelich.de/record/862752/files/%CE%B1-Synuclein-derived%20lipoparticles%20in%20the%20study%20of%20%CE%B1-Synuclein%20amyloid%20fibril%20formation.pdf$$yOpenAccess
000862752 8564_ $$uhttps://juser.fz-juelich.de/record/862752/files/%CE%B1-Synuclein-derived%20lipoparticles%20in%20the%20study%20of%20%CE%B1-Synuclein%20amyloid%20fibril%20formation.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000862752 909CO $$ooai:juser.fz-juelich.de:862752$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000862752 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177882$$aForschungszentrum Jülich$$b4$$kFZJ
000862752 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132018$$aForschungszentrum Jülich$$b5$$kFZJ
000862752 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166306$$aForschungszentrum Jülich$$b7$$kFZJ
000862752 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156341$$aForschungszentrum Jülich$$b8$$kFZJ
000862752 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000862752 9141_ $$y2019
000862752 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000862752 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000862752 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000862752 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000862752 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCHEM PHYS LIPIDS : 2017
000862752 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000862752 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000862752 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000862752 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000862752 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000862752 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000862752 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000862752 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000862752 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000862752 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000862752 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000862752 920__ $$lyes
000862752 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000862752 9801_ $$aFullTexts
000862752 980__ $$ajournal
000862752 980__ $$aVDB
000862752 980__ $$aUNRESTRICTED
000862752 980__ $$aI:(DE-Juel1)ICS-6-20110106
000862752 981__ $$aI:(DE-Juel1)IBI-7-20200312